Vimarsana
Biggest News Aggregation in the World

Prof Van Cutsem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prof Van Cutsem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prof Van Cutsem Today - Breaking & Trending Today

Cantargia AB: Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023 - Vimarsana News

Cantargia AB: Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023

Published: April 4, 2023

LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day focusing on new clinical results and biomarker data for

Source: finanznachrichten.de
Related Topics:
Region FlamandeDavid LibergVan CutsemDominique TersagoEric Van CutsemPrnewswire CantargiaUniversity Hospitals GasthuisbergVp ResearchUniversity Of WarsawBelgian FoundationNasdaq StockholmDivision HeadDigestive OncologyEric VanMedical UniversityProf Van CutsemBelgian Royal Academy
Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023 - Vimarsana News

Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023

Published: April 4, 2023

LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today...

Source: europapress.es
Related Topics:
Region FlamandeVan CutsemEric Van CutsemPhderic Van CutsemDominique TersagoDavid LibergPrnewswire CantargiaUniversity Hospitals GasthuisbergVp ResearchBelgian FoundationUniversity Of WarsawNasdaq StockholmDivision HeadDigestive OncologyEric VanMedical UniversityProf Van CutsemBelgian Royal Academy
Cantargia AB: Cantargia to host R&D Day on nadunolimab combinational synergy in pancreatic cancer and non-small cell lung cancer - Vimarsana News

Cantargia AB: Cantargia to host R&D Day on nadunolimab combinational synergy in pancreatic cancer and non-small cell lung cancer

Published: June 9, 2022

STOCKHOLM, June 9, 2022 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day on Thursday, June 16, 2022 at 09:00 AM EDT (3:00 PM CET), focusing

Source: finanznachrichten.de
Related Topics:
Region FlamandeUnited StatesLos AngelesSudheer DossPrnewswire CantargiaLuniversidad ComplutenseLuis PazEric Van CutsemVan CutsemUniversity Of CaliforniaBelgian FoundationUniversity Of WarsawOncology DepartmentUniversity Hospitals GasthuisbergNational Oncology Research CenterPancreatic Cancer Action Network PanNasdaq StockholmProf Eric Van CutsemProf Van CutsemChief Business OfficerPancreatic Cancer Action NetworkDivision HeadDigestive OncologyMedical UniversityBelgian Royal Academy
Cantargia to host R&D Day on nadunolimab combinational synergy in pancreatic cancer and non-small cell lung cancer - Vimarsana News

Cantargia to host R&D Day on nadunolimab combinational synergy in pancreatic cancer and non-small cell lung cancer

Published: June 9, 2022

/PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day on Thursday, June 16, 2022 at 09:00 AM EDT (3:00 PM...

Source: prnewswire.co.uk
Related Topics:
Region FlamandeUnited StatesLos AngelesSudheer DossLuniversidad ComplutenseLuis PazEric Van CutsemVan CutsemUniversity Of CaliforniaBelgian FoundationUniversity Of WarsawOncology DepartmentUniversity Hospitals GasthuisbergNational Oncology Research CenterPancreatic Cancer Action Network PanNasdaq StockholmProf Eric Van CutsemProf Van CutsemChief Business OfficerPancreatic Cancer Action NetworkDivision HeadDigestive OncologyMedical UniversityBelgian Royal AcademyLuis Paz Ares